Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - galantaminum brómíð - hart forðahylki - 24 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - galantaminum brómíð - hart forðahylki - 8 mg

Union européenne - islandais - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - treosulfan - blóðmyndandi stofnfrumnaígræðsla - Æxlishemjandi lyf - treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (allohsct) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.